Article
Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.
International journal of hematology - 1 Apr 2014
Kawajiri Chika, Tanaka Hiroaki, Hashimoto Shinichiro, Takeda Yusuke, Sakai Shio, Takagi Toshiyuki, Takeuchi Masahiro, Ohwada Chikako, Sakaida Emiko, Shimizu Naomi, Nakaseko Chiaki
Abstract excerpt
Philadelphia chromosome-positive mixed phenotype acute leukemia (Ph(+)MPAL) is a rare type of acute leukemia having myeloid and lymphoid features. In the present study, we describe the successful treatment of a 71-year-old Japanese female patient with Ph(+)MPAL by the alternation of second-genera...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.